Thyroid Cancer Recurrence: What to Ask

For papillary and follicular thyroid cancer, a blood protein called thyroglobulin does most of the work in follow-up.

NCI is direct about it. A raised thyroglobulin level after surgery correlates strongly with cancer having returned.

There is a catch in how the test behaves. NCI says thyroglobulin is most sensitive when your thyroid hormone is low and TSH is high. Preparing for the test therefore involves raising TSH. There are two ways this is done: by pausing or altering the thyroid hormone tablet for a set period, or by giving recombinant TSH by injection so the tablet can continue. Which route suits you is an endocrinology decision.

Never stop, reduce or change your thyroid hormone yourself, and never skip doses in preparation for a test or a scan unless endocrinology has told you to, in writing, with dates. Ask which conditions your sample was taken under, and whether it can be compared with your earlier results.

This is worth understanding, because it explains the follow-up. NCI says the goal of radioactive iodine after surgery is to destroy leftover normal thyroid tissue.

That is not only about cancer. Removing the remnant makes the thyroglobulin test more meaningful and lets a whole-body scan pick up disease that is still there.

NCI adds that a large remnant makes a low thyroglobulin impossible to reach, which can mean more doses.

NCI describes careful follow-up for differentiated thyroid cancer. It uses physical examinations, quantitative thyroglobulin blood tests, and imaging chosen according to individual risk.

Risk-based means your schedule may differ from someone else's, and it should. Ask what risk group you are in and why.

Not every recurrence takes up iodine. NCI lists what decides the next step. It is the cell type, and whether the tumor takes up iodine. It is also what treatment you have already had, where the recurrence sits, and your own preferences.

It also names one more thing on that list. Whether the tumor carries an activating RET or NTRK gene fusion.

For recurrent papillary and follicular cancer, NCI lists surgery with or without iodine, and targeted therapy. It also lists tyrosine kinase inhibitors, RET inhibitors, NTRK inhibitors, external beam radiation and chemotherapy.

NCI reports that in differentiated thyroid cancer, people whose recurrence is picked up only by an iodine scan have a better outlook than those whose recurrence is clinically obvious. That is a comparison between two groups, not a forecast: where the disease is, how much there is, whether it still takes up iodine and what treatment is open all move the answer. Medullary and anaplastic disease are followed and judged on their own terms.

That is an argument for taking the scan seriously, not for dreading it.

Medullary cancer usually makes calcitonin. NCI says calcitonin can be found in the blood even when the tumor cannot be seen. Measuring it is useful both for diagnosis and for following treatment.

If yours is medullary, ask whether RET testing was done. NCI says everyone with this type is tested, and that relatives are tested when a variant is found.

• What is my thyroglobulin now, and what was it before?
• Was the sample taken on or off my hormone tablet?
• Which risk group am I in, and what schedule does that set?
• Did my neck ultrasound find anything that needs a biopsy?
• Does my tumor still take up iodine?
• Has the tumor been tested for RET or NTRK changes?
• If iodine will not work, which treatment comes next?

Most thyroid recurrences are found by a blood test or a scan, not by a symptom. A few things should not wait for the next appointment.

• Call 911 or go to an emergency department if breathing becomes difficult or noisy, or the airway feels like it is closing. A recurrence in the neck can press on the windpipe.
• Call your care team the same day if you notice a new neck lump, a new or worsening hoarse voice, trouble swallowing, or pain on swallowing. NCI lists all of these as signs of thyroid cancer.
• Call your care team within a day or two if you get tingling in the lips, fingers or toes, or muscle cramps. After thyroid surgery these can mean the blood calcium is low, which is treatable.

If a term above is new, Cancer Staging and Biomarker Testing cover the ones that come up most in thyroid follow-up. For what to do with the answers, see Clinical Trial vs Standard Treatment, Palliative Care, and Questions to Ask Your Doctor.

These questions were drawn from current patient guidance for thyroid cancer:

• NCI PDQ - Thyroid Cancer Treatment (Patient Version).
• NCI PDQ - Thyroid Cancer Treatment (Health Professional Version).
• MedlinePlus - Hypoparathyroidism.